In experimental models, BCAT1 overexpression promotes breast cancer cell proliferation and invasiveness, partly by supplying intermediates to the TCA cycle and activating mTOR signaling to enhance mitochondrial biogenesis [50]. Here, BCAT1 is linked to breast cancer.